File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: A framework for in-field and out-of-field patient specific secondary cancer risk estimates from treatment plans using the TOPAS Monte Carlo system

TitleA framework for in-field and out-of-field patient specific secondary cancer risk estimates from treatment plans using the TOPAS Monte Carlo system
Authors
Keywordscomputational phantoms
Monte Carlo dose calculation
out-of-field dose
second cancer risk
Issue Date2024
Citation
Physics in Medicine and Biology, 2024, v. 69, n. 16, article no. 165023 How to Cite?
AbstractObjective. To allow the estimation of secondary cancer risks from radiation therapy treatment plans in a comprehensive and user-friendly Monte Carlo (MC) framework. Method. Patient planning computed tomography scans were extended superior-inferior using the International Commission on Radiological Protection’s Publication 145 computational mesh phantoms and skeletal matching. Dose distributions were calculated with the TOPAS MC system using novel mesh capabilities and the digital imaging and communications in medicine radiotherapy extension interface. Finally, in-field and out-of-field cancer risk was calculated using both sarcoma and carcinoma risk models with two alternative parameter sets. Result. The TOPAS MC framework was extended to facilitate epidemiological studies on radiation-induced cancer risk. The framework is efficient and allows automated analysis of large datasets. Out-of-field organ dose was small compared to in-field dose, but the risk estimates indicate a non-negligible contribution to the total radiation induced cancer risk. Significance. This work equips the TOPAS MC system with anatomical extension, mesh geometry, and cancer risk model capabilities that make state-of-the-art out-of-field dose calculation and risk estimation accessible to a large pool of users. Furthermore, these capabilities will facilitate further refinement of risk models and sensitivity analysis of patient specific treatment options.
Persistent Identifierhttp://hdl.handle.net/10722/345829
ISSN
2023 Impact Factor: 3.3
2023 SCImago Journal Rankings: 0.972

 

DC FieldValueLanguage
dc.contributor.authorMeyer, Isaac-
dc.contributor.authorPeters, Nils-
dc.contributor.authorTamborino, Giulia-
dc.contributor.authorLee, Hoyeon-
dc.contributor.authorBertolet, Alejandro-
dc.contributor.authorFaddegon, Bruce-
dc.contributor.authorMille, Matthew M.-
dc.contributor.authorLee, Choonsik-
dc.contributor.authorSchuemann, Jan-
dc.contributor.authorPaganetti, Harald-
dc.date.accessioned2024-09-01T11:00:00Z-
dc.date.available2024-09-01T11:00:00Z-
dc.date.issued2024-
dc.identifier.citationPhysics in Medicine and Biology, 2024, v. 69, n. 16, article no. 165023-
dc.identifier.issn0031-9155-
dc.identifier.urihttp://hdl.handle.net/10722/345829-
dc.description.abstractObjective. To allow the estimation of secondary cancer risks from radiation therapy treatment plans in a comprehensive and user-friendly Monte Carlo (MC) framework. Method. Patient planning computed tomography scans were extended superior-inferior using the International Commission on Radiological Protection’s Publication 145 computational mesh phantoms and skeletal matching. Dose distributions were calculated with the TOPAS MC system using novel mesh capabilities and the digital imaging and communications in medicine radiotherapy extension interface. Finally, in-field and out-of-field cancer risk was calculated using both sarcoma and carcinoma risk models with two alternative parameter sets. Result. The TOPAS MC framework was extended to facilitate epidemiological studies on radiation-induced cancer risk. The framework is efficient and allows automated analysis of large datasets. Out-of-field organ dose was small compared to in-field dose, but the risk estimates indicate a non-negligible contribution to the total radiation induced cancer risk. Significance. This work equips the TOPAS MC system with anatomical extension, mesh geometry, and cancer risk model capabilities that make state-of-the-art out-of-field dose calculation and risk estimation accessible to a large pool of users. Furthermore, these capabilities will facilitate further refinement of risk models and sensitivity analysis of patient specific treatment options.-
dc.languageeng-
dc.relation.ispartofPhysics in Medicine and Biology-
dc.subjectcomputational phantoms-
dc.subjectMonte Carlo dose calculation-
dc.subjectout-of-field dose-
dc.subjectsecond cancer risk-
dc.titleA framework for in-field and out-of-field patient specific secondary cancer risk estimates from treatment plans using the TOPAS Monte Carlo system-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1088/1361-6560/ad64b6-
dc.identifier.pmid39019051-
dc.identifier.scopuseid_2-s2.0-85200703929-
dc.identifier.volume69-
dc.identifier.issue16-
dc.identifier.spagearticle no. 165023-
dc.identifier.epagearticle no. 165023-
dc.identifier.eissn1361-6560-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats